Publikation
Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS).
Wissenschaftlicher Artikel/Review - 26.01.2023
Achtnichts Lutz, Zecca Chiara, Findling Oliver, Kamm Christian Philipp, Müller Stefanie, Kuhle Jens, Lutterotti Andreas, Gobbi Claudio, Viviani Camille, Villiger-Borter Emanuela, Nedeltchev Krassen
Bereiche
PubMed
DOI
Kontakt
Zitation
Achtnichts L, Zecca C, Findling O, Kamm C, Müller S, Kuhle J, Lutterotti A, Gobbi C, Viviani C, Villiger-Borter E, Nedeltchev K. Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS). BMJ Neurol Open 2023; 5:e000304.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
BMJ Neurol Open 2023; 5
Veröffentlichungsdatum
26.01.2023
eISSN (Online)
2632-6140
Seiten
e000304
Kurzbeschreibung/Zielsetzung
In patients with multiple sclerosis (MS), relapses and disability progression have been associated with decreased health-related quality of life (HRQoL).